Review
Biochemistry & Molecular Biology
Massimo Ubaldi, Nazzareno Cannella, Anna Maria Borruto, Michele Petrella, Maria Vittoria Micioni Di Bonaventura, Laura Soverchia, Serena Stopponi, Friedbert Weiss, Carlo Cifani, Roberto Ciccocioppo
Summary: Nociceptin/orphanin FQ (N/OFQ) is a neuropeptide that binds the NOP receptor and exerts anti-opioids effects; the NOP receptor is widely expressed in the brain, while N/OFQ is mainly localized in stress-related brain nuclei; preclinical evidence suggests that both NOP agonists and antagonists may be effective therapeutic approaches for substance use disorders.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Review
Biochemistry & Molecular Biology
Amal El Daibani, Tao Che
Summary: In our society today, pain has become a significant source of strain on individuals. Developing new pain treatments with fewer adverse effects is crucial. The NOP receptor has emerged as a promising focal point for novel pain therapies, offering an alternative to opioid morphine with potential life-threatening effects and addiction. This article reviews the molecular and cellular structure controlling the cellular trafficking of the NOP receptor and presents studies supporting its role in pain management.
Article
Psychiatry
Fangmin Wang, Wenwen Shen, Yujia Cai, Xin Zhang, Han Du, Miaojun Lai, Huifen Liu, Evelyne Kohli, Wenhua Zhou
Summary: Buprenorphine can reduce METH intake and drug-seeking behavior by activating NOP receptors.
FRONTIERS IN PSYCHIATRY
(2022)
Article
Pharmacology & Pharmacy
Mark F. Bird, Christopher P. Hebbes, Anushuya Tamang, Jonathon Mark Willets, Jonathan P. Thompson, Remo Guerrini, Girolamo Calo, David G. Lambert
Summary: In this study, the role of N/OFQ-NOP system was explored in freshly isolated volunteer human B- and T-cells incubated with LPS and PepG as a model of in vitro sepsis. The findings suggest that N/OFQ-NOP receptors play a regulatory role in B and T cell function, inhibiting cell migration and reducing GM-CSF release to variable degrees.
BRITISH JOURNAL OF PHARMACOLOGY
(2023)
Article
Pharmacology & Pharmacy
Clarissa A. Pisano, Daniela Mercatelli, Martina Mazzocchi, Alberto Brugnoli, Ilaria Morella, Stefania Fasano, Nurulain T. Zaveri, Riccardo Brambilla, Gerard W. O'Keeffe, Richard R. Neubig, Michele Morari
Summary: The study indicates that RGS4 physiologically inhibits NOP receptor signaling and the chemical probe CCG-203920 can enhance NOP responses and improve the antidyskinetic potential of NOP receptor agonists.
BRITISH JOURNAL OF PHARMACOLOGY
(2023)
Article
Pharmacology & Pharmacy
Sonny H. J. Sliepen, Johanna Korioth, Thomas Christoph, Thomas M. Tzschentke, Marta Diaz-delCastillo, Anne-Marie Heegaard, Kris Rutten
Summary: This study investigated the analgesic potential of NOP receptor activation in a rodent cancer-induced bone pain model, finding that Nociceptin and Ro65-6570 could inhibit cancer-induced mechanical allodynia, with J-113397 selectively antagonizing the effect of Ro65-6570. Additionally, MRMT-1/Luc2-bearing animals showed elevated plasma cytokine levels and altered expression of NOP-r gene in DRG and bone marrow.
BRITISH JOURNAL OF PHARMACOLOGY
(2021)
Review
Pharmacology & Pharmacy
Omar N. Al Yacoub, Hibah O. Awwad, Yong Zhang, Kelly M. Standifer
Summary: This article reviews the role of the N/OFQ-NOP receptor system in the neurological and behavioral sequelae of PTSD and TBI. The current findings suggest that NOP modulators may have potential as therapeutics for these disorders and their co-morbidities. The authors advocate for the development of standards for common data elements reporting to improve reproducibility and data sharing.
PHARMACOLOGY & THERAPEUTICS
(2022)
Article
Biochemistry & Molecular Biology
Elaine C. Gavioli, Victor A. D. Holanda, Girolamo Calo, Chiara Ruzza
Summary: Resilience plays a crucial role in mental health, and understanding its mechanisms can improve treatment outcomes and help high-risk individuals. The N/OFQ-NOP system is central to stress response, affecting hormone secretion, behavior, and psychopathologies.
Article
Neurosciences
Wenfu Li, Zhiheng Ren, Ying Tang, Yixin Fu, Shizhu Sun, Ruxuan Ding, Jiawei Hou, Yunlin Mai, Bo Zhan, Yingxin Zhu, Wanhong Zuo, Jiang-Hong Ye, Rao Fu
Summary: Recent studies suggest that the stimulation of the rostromedial tegmental nucleus (RMTg) and the role of the nociceptin/orphanin FQ (N/OFQ) system may be involved in affective disorders and drug addiction. This study found that N/OFQ signaling contributes to changes in behavior and RMTg activity of rats during alcohol withdrawal. The deficiency of RMTg N/OFQ signaling mediates anxiety- and depression-like behaviors in alcohol withdrawn rats, and the intervention of the N/OFQ system may potentially help individuals with alcohol use disorders.
NEUROPSYCHOPHARMACOLOGY
(2023)
Article
Chemistry, Medicinal
Luca Blicker, Rafael Gonzalez-Cano, Erik Laurini, Francisco R. Nieto, Judith Schmidt, Dirk Schepmann, Sabrina Pricl, Bernhard Wuensch
Summary: Antagonists at a1 receptors have great potential for treating neuropathic pain. The study examined different compounds and found that amino-diols showed higher a1 affinity than bicyclic and tricyclic derivatives. The configuration and structure of the compounds also influenced their a1 affinity and selectivity. A specific compound, aminodiol 8b, demonstrated high a1 affinity, selectivity, and promising activity in pain relief.
JOURNAL OF MEDICINAL CHEMISTRY
(2023)
Article
Chemistry, Medicinal
Luca Blicker, Rafael Gonzalez-Cano, Erik Laurini, Francisco R. Nieto, Judith Schmidt, Dirk Schepmann, Sabrina Pricl, Bernhard Wunsch
Summary: Antagonists targeting sigma 1 receptors show promise for neuropathic pain treatment. A series of aminodiols were synthesized from (-)-isopulegol (1) and transformed into bicyclic and tricyclic derivatives. The aminodiols exhibited higher sigma 1 affinity compared to the derivatives. The study also revealed the importance of stereochemistry and compound structure in modulating sigma 1 affinity.
JOURNAL OF MEDICINAL CHEMISTRY
(2023)
Article
Pharmacology & Pharmacy
Omar N. Al Yacoub, Stefano Tarantini, Yong Zhang, Anna Csiszar, Kelly M. Standifer
Summary: Traumatic brain injury (TBI) affects millions of people each year and is a leading cause of death and disability. This study suggests that the N/OFQ-NOP receptor pathway plays a significant role in regulating cerebral blood flow and injury markers in TBI, indicating that the NOP receptor could be a potential therapeutic target for TBI.
FRONTIERS IN PHARMACOLOGY
(2023)
Article
Biochemistry & Molecular Biology
Rosa Ester Forgione, Ferran Fabregat Nieto, Cristina Di Carluccio, Francesco Milanesi, Martina Fruscella, Francesco Papi, Cristina Nativi, Antonio Molinaro, Pasquale Palladino, Simona Scarano, Maria Minunni, Marco Montefiori, Monica Civera, Sara Sattin, Oscar Francesconi, Roberta Marchetti, Alba Silipo
Summary: In this study, two conformationally constrained sialyl analogues were synthesized and characterized for their interaction with human CD22 protein. The results demonstrate the potential of these analogues as novel CD22 inhibitors and provide new insights for modifying and synthesizing sialic acid. Furthermore, they offer promising prospects for therapeutic intervention in autoimmune diseases and B-cell malignancies.
Article
Neurosciences
Sarah Sayers, Nikki Le, Jennifer Hernandez, Veronica Mata-Pacheco, Edward J. Wagner
Summary: N/OFQ(ARC) neurons play a vital role in promoting rebound hyperphagia by inhibiting anorexigenic neural substrates under negative energy balance conditions, an effect that is diminished by E-2 in females.
JOURNAL OF PHYSIOLOGY-LONDON
(2022)
Article
Clinical Neurology
Zhengyu Liao, Hu Long, Zhiping Song, Yuwei He, Wenli Lai
Summary: The mouth-wiping behavior of rats increased significantly after experimental tooth movement, showing cyclical variation. N/OFQ immunoreactivity increased in the periodontal ligament, while ppN/OFQ mRNA and protein levels in the TG were positively correlated with pain stimulus. Large fluctuations were observed in NOP gene levels.
PAIN RESEARCH & MANAGEMENT
(2021)